KMT9-IN-2 (Compound 7b) is an active form of a KMT9 inhibitor with a dissociation constant (Kd) of 10 nM. This compound is applicable for research in colon cancer.
Target:
Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
